Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03746002 · ClinicalTrials.gov registry record · Phase 4
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT03746002 is a Phase 4 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 3 participants.
The verdict
NCT03746002, a Phase 4 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether administering metolazone 60 minutes prior to furosemide increases urine output compared with administering metolazone and furosemide concomitantly. Participants will have equal chance of being assigned to each group.
Interventions
- DRUG Metolazone 60 minutes prior to furosemide
- DRUG Metolazone concurrently with furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-01-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03746002
The ClinicalTrials.gov registry entry for NCT03746002 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metolazone 60 minutes prior to furosemide is the first listed.
NCT03746002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03746002 about?
NCT03746002 is a clinical study titled "Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing". The purpose of this study is to examine whether administering metolazone 60 minutes prior to furosemide increases urine output compared with administering metolazone and furosemide concomitantly. Participants will have equal chance of being assigned to each group.
What is the current status of trial NCT03746002?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2019-01-01. Estimated completion is 2020-01-10.
What interventions are being tested in trial NCT03746002?
The interventions under investigation include: Metolazone 60 minutes prior to furosemide (DRUG), Metolazone concurrently with furosemide (DRUG).
Who is sponsoring clinical trial NCT03746002?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.